24 results
8-K
EX-99.1
PHAT
Phathom Pharmaceuticals Inc
9 Nov 23
Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
8:05am
of this novel dosing regimen.
Phathom has completed the onboarding of its sales leadership team and is finalizing the hiring and onboarding
PRE 14A
z7igrj7lj6449tw
31 Mar 23
Preliminary proxy
4:06pm
8-K
EX-99.1
71zdyc9 kbncb4j2w
9 Nov 22
Phathom Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updates
8:06am
8-K
EX-99.1
52xwop0us2paeeialrt
10 May 22
Phathom Pharmaceuticals Reports First Quarter 2022 Results and Provides Recent
8:06am
8-K
EX-99.1
eqofna3e hra67
6 Aug 20
Phathom Pharmaceuticals Reports Second Quarter 2020 Results
8:35am
8-K
2gzxwhothm qo18su1
13 Jul 20
Departure of Directors or Certain Officers
8:36am
DEF 14A
k5oaaxs6ht ykam
8 Apr 20
Definitive proxy
8:31am
8-K
EX-99.1
4z464hsiqqbx sb2hz9
19 Mar 20
Phathom Reports Fourth Quarter and Full Year 2019 Financial
8:36am
8-K
bdjt3kjfet
2 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
hh8co9qx2
25 Nov 19
Phathom Pharmaceuticals Reports Third Quarter 2019
8:30am
424B4
mcaxfdb9vh
28 Oct 19
Prospectus supplement with pricing info
12:00am